{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:33:00Z","timestamp":1781901180437,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Injection drug use (IDU) is one of the most significant risk factors for viral hepatitis (B and C) and human immunodeficiency virus (HIV) infections. This study assessed seroprevalence rates of hepatitis B virus (HBV), hepatitis C virus (HCV) and\u00a0human immunodeficiency virus (HIV) in people who inject drugs (PWID) in Kuwait. We conducted a cross-sectional study from April to September 2017. A total of 521 consecutive subjects, admitted at Al-Sabah Hospital. The serological and virological markers of HBV, HCV, and HIV were tested\u00a0 using automated platforms. The mean age of the participants was 32.26\u2009yrs, and the sex ratio (Male\/Female) was 15.28. The prevalence rates of HBsAg, anti-HCV, and anti-HIV antibodies were 0.38% (95% CI: 0.07\u20131.53%), 12.28% (95% CI: 9.65\u201315.48), and 0.77% (95% CI: 0.25\u20132.23%), respectively. HCV-RNA was evident in 51.72% (95% CI: 38.34\u201364.87%) among anti-HCV positive participants. Multivariate analysis showed that the high prevalence of HCV infection amongst PWID is associated with age. Whereas, multivariate analysis revealed no significant associations with age and gender regarding HIV and HBV infections. The results suggest that high rates of HBV, HCV, and HIV infections among injecting drug users than the general population. These findings emphasize the importance of introducing interventions and harm reduction initiatives that have a high impact on reducing needle sharing.<\/jats:p>","DOI":"10.1038\/s41598-019-42810-w","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T10:08:13Z","timestamp":1555582093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study"],"prefix":"10.1038","volume":"9","author":[{"given":"Haya","family":"Altawalah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Essa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-6163","authenticated-orcid":false,"given":"Sayeh","family":"Ezzikouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Widad","family":"Al-Nakib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"key":"42810_CR1","unstructured":"WHO. In WHO guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO WHO Guidelines Approved by the Guidelines Review Committee (2017)."},{"key":"42810_CR2","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt, L. et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health 5, e1192\u2013e1207, https:\/\/doi.org\/10.1016\/S2214-109X(17)30375-3 (2017).","journal-title":"Lancet Glob Health"},{"key":"42810_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25102","volume":"21","author":"GR Mumtaz","year":"2018","unstructured":"Mumtaz, G. R., Awad, S. F., Feizzadeh, A., Weiss, H. A. & Abu-Raddad, L. J. HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis. J Int AIDS Soc 21, e25102, https:\/\/doi.org\/10.1002\/jia2.25102 (2018).","journal-title":"J Int AIDS Soc"},{"key":"42810_CR4","first-page":"225","volume":"59","author":"G Edwards","year":"1981","unstructured":"Edwards, G., Arif, A. & Hadgson, R. Nomenclature and classification of drug- and alcohol-related problems: a WHO Memorandum. Bull World Health Organ 59, 225\u2013242 (1981).","journal-title":"Bull World Health Organ"},{"key":"42810_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000110407","volume":"14","author":"N Abdala","year":"2008","unstructured":"Abdala, N. et al. Sexually transmitted infections, sexual risk behaviors and the risk of heterosexual spread of HIV among and beyond IDUs in St. Petersburg, Russia. Eur Addict Res 14, 19\u201325, https:\/\/doi.org\/10.1159\/000110407 (2008).","journal-title":"Eur Addict Res"},{"key":"42810_CR6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0140-6736(16)30769-3","volume":"388","author":"A Kamarulzaman","year":"2016","unstructured":"Kamarulzaman, A. et al. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. Lancet 388, 1115\u20131126, https:\/\/doi.org\/10.1016\/S0140-6736(16)30769-3 (2016).","journal-title":"Lancet"},{"key":"42810_CR7","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1023\/A:1010833917242","volume":"16","author":"PB Christensen","year":"2000","unstructured":"Christensen, P. B., Krarup, H. B., Niesters, H. G., Norder, H. & Georgsen, J. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol 16, 1043\u20131049 (2000).","journal-title":"Eur J Epidemiol"},{"key":"42810_CR8","doi-asserted-by":"publisher","first-page":"e0134455","DOI":"10.1371\/journal.pone.0134455","volume":"10","author":"HT Kinkel","year":"2015","unstructured":"Kinkel, H. T. et al. Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal. PLoS One 10, e0134455, https:\/\/doi.org\/10.1371\/journal.pone.0134455 (2015).","journal-title":"PLoS One"},{"key":"42810_CR9","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1080\/09540121.2014.882485","volume":"26","author":"A Ramezani","year":"2014","unstructured":"Ramezani, A. et al. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran. AIDS Care 26, 1122\u20131126, https:\/\/doi.org\/10.1080\/09540121.2014.882485 (2014).","journal-title":"AIDS Care"},{"key":"42810_CR10","doi-asserted-by":"publisher","first-page":"e16349","DOI":"10.1371\/journal.pone.0016349","volume":"6","author":"YH Zhou","year":"2011","unstructured":"Zhou, Y. H. et al. Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region. PLoS One 6, e16349, https:\/\/doi.org\/10.1371\/journal.pone.0016349 (2011).","journal-title":"PLoS One"},{"issue":"Suppl 5","key":"42810_CR11","doi-asserted-by":"publisher","first-page":"S348","DOI":"10.1086\/377560","volume":"37","author":"M Weissenbacher","year":"2003","unstructured":"Weissenbacher, M. et al. High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina. Clin Infect Dis 37(Suppl 5), S348\u2013352, https:\/\/doi.org\/10.1086\/377560 (2003).","journal-title":"Clin Infect Dis"},{"key":"42810_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-10-657","volume":"10","author":"J Wu","year":"2010","unstructured":"Wu, J. et al. Infection status and risk factors of HIV, HBV, HCV, and syphilis among drug users in Guangdong, China\u2013a cross-sectional study. BMC Public Health 10, 657, https:\/\/doi.org\/10.1186\/1471-2458-10-657 (2010).","journal-title":"BMC Public Health"},{"key":"42810_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-016-3545-4","volume":"16","author":"B Wenz","year":"2016","unstructured":"Wenz, B. et al. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011\u201314). BMC Public Health 16, 927, https:\/\/doi.org\/10.1186\/s12889-016-3545-4 (2016).","journal-title":"BMC Public Health"},{"key":"42810_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11524-017-0207-5","volume":"95","author":"E Spada","year":"2018","unstructured":"Spada, E. et al. Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy. J Urban Health 95, 99\u2013110, https:\/\/doi.org\/10.1007\/s11524-017-0207-5 (2018).","journal-title":"J Urban Health"},{"key":"42810_CR15","first-page":"852","volume":"21","author":"RA Al-Owaish","year":"2000","unstructured":"Al-Owaish, R. A., Anwar, S., Sharma, P. & Shah, S. F. HIV\/AIDS prevalence among male patients in Kuwait. Saudi Med J 21, 852\u2013859 (2000).","journal-title":"Saudi Med J"},{"key":"42810_CR16","unstructured":"Factbook, C. W. HIV\/AIDS - ADULT PREVALENCE RATE (2018)."},{"key":"42810_CR17","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1016\/j.ijid.2009.03.002","volume":"14","author":"A Rahimi-Movaghar","year":"2010","unstructured":"Rahimi-Movaghar, A., Razaghi, E. M., Sahimi-Izadian, E. & Amin-Esmaeili, M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis 14, e28\u201333, https:\/\/doi.org\/10.1016\/j.ijid.2009.03.002 (2010).","journal-title":"Int J Infect Dis"},{"key":"42810_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1360-0443.2009.02759.x","volume":"105","author":"P Vickerman","year":"2010","unstructured":"Vickerman, P., Hickman, M., May, M., Kretzschmar, M. & Wiessing, L. Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction 105, 311\u2013318, https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02759.x (2010).","journal-title":"Addiction"},{"key":"42810_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-108","volume":"8","author":"M Kretzschmar","year":"2008","unstructured":"Kretzschmar, M. et al. Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? BMC Infect Dis 8, 108, https:\/\/doi.org\/10.1186\/1471-2334-8-108 (2008).","journal-title":"BMC Infect Dis"},{"key":"42810_CR20","doi-asserted-by":"publisher","first-page":"e42937","DOI":"10.1371\/journal.pone.0042937","volume":"7","author":"YH Zhou","year":"2012","unstructured":"Zhou, Y. H. et al. High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China. PLoS One 7, e42937, https:\/\/doi.org\/10.1371\/journal.pone.0042937 (2012).","journal-title":"PLoS One"},{"key":"42810_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jiph.2011.05.004","volume":"4","author":"W Chehadeh","year":"2011","unstructured":"Chehadeh, W. et al. Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications. J Infect Public Health 4, 200\u2013206, https:\/\/doi.org\/10.1016\/j.jiph.2011.05.004 (2011).","journal-title":"J Infect Public Health"},{"key":"42810_CR22","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/j.1537-2995.2005.00635.x","volume":"45","author":"R Ameen","year":"2005","unstructured":"Ameen, R. et al. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 45, 1973\u20131980, https:\/\/doi.org\/10.1111\/j.1537-2995.2005.00635.x (2005).","journal-title":"Transfusion"},{"key":"42810_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ijid.2016.03.012","volume":"46","author":"YA Mohamoud","year":"2016","unstructured":"Mohamoud, Y. A., Riome, S. & Abu-Raddad, L. J. Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence. Int J Infect Dis 46, 116\u2013125, https:\/\/doi.org\/10.1016\/j.ijid.2016.03.012 (2016).","journal-title":"Int J Infect Dis"},{"key":"42810_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/tropej\/44.5.311","volume":"44","author":"L al-Fuzae","year":"1998","unstructured":"al-Fuzae, L., Aboolbacker, K. C. & al-Saleh, Q. beta-Thalassaemia major in Kuwait. J Trop Pediatr 44, 311\u2013312 (1998).","journal-title":"J Trop Pediatr"},{"key":"42810_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jhep.2017.10.010","volume":"68","author":"H Fraser","year":"2018","unstructured":"Fraser, H. et al. Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. J Hepatol 68, 402\u2013411, https:\/\/doi.org\/10.1016\/j.jhep.2017.10.010 (2018).","journal-title":"J Hepatol"},{"key":"42810_CR26","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G. & Ott, J. J. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386, 1546\u20131555, https:\/\/doi.org\/10.1016\/S0140-6736(15)61412-X (2015).","journal-title":"Lancet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42810-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42810-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42810-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:57:54Z","timestamp":1671267474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42810-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42810"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42810-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,18]]},"assertion":[{"value":"3 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6292"}}